×

This article on Epainassist.com has been reviewed by a medical professional, as well as checked for facts, to assure the readers the best possible accuracy.

We follow a strict editorial policy and we have a zero-tolerance policy regarding any level of plagiarism. Our articles are resourced from reputable online pages. This article may contains scientific references. The numbers in the parentheses (1, 2, 3) are clickable links to peer-reviewed scientific papers.

The feedback link “Was this Article Helpful” on this page can be used to report content that is not accurate, up-to-date or questionable in any manner.

This article does not provide medical advice.

1

Exploring the Link : Bacteriophages and Parkinson’s Disease Connection

Bacteriophages, commonly known as phages, are regarded as the most abundant organisms existing on Earth. Wherever bacteria thrive, phages are inevitably going to be present alongside them. Their historical use has involved fighting bacterial infections before the advent of antibiotics. However, over the years, their popularity declined with the emergence of antibiotics, which presented a cheaper and more convenient alternative.(1,2)

In recent times, though, there has been a surge of interest in these minute entities once again. As research teams uncover increasingly significant roles played by gut bacteria in maintaining both health and contributing to diseases, attention has now turned towards understanding the importance of phages in this context. 

New research now suggests that bacteriophages, viruses that target bacteria, might have a significant impact on the onset of Parkinson’s disease. These findings offer an intriguing and novel perspective on understanding the condition. Read on to find out if there could be a potential connection between bacteriophages and Parkinson’s disease.

Exploring the Connection between Bacteriophages and Parkinson’s Disease

Researchers led by Dr. George Tetz from the Human Microbiology Institute in New York City recently presented their study findings at the ASM Microbe, which is the annual meeting of the American Society for Microbiology held in Atlanta, Georgia.(3,4) Their investigation aimed to understand the potential influence of phages on the development of Parkinson’s disease.

In addition to the well-known motor symptoms, Parkinson’s disease is often associated with gastrointestinal issues, which some scientists consider to be an early indicator of the condition.(5) Yet, research focusing on Parkinson’s and its connection with gut-related factors remains relatively unexplored.

The study focused on Lactococcus bacteria and the corresponding phages that target them. Lactococcus bacteria are believed to affect gut permeability, influencing the passage of nutrients and pathogens between gut cells.(6) These bacteria also play a role in dopamine production, a crucial neurotransmitter linked to Parkinson’s disease.

What the Study Showed: Lactococcus Phages in Parkinson’s 

To examine any potential relationship between bacteria, phages, and Parkinson’s, the researchers analyzed stool samples from 32 Parkinson’s patients and 28 control subjects.

The research revealed an intriguing discovery regarding the abundance of Lactococcus-targeting phages in individuals with Parkinson’s disease. The study found a significant increase in these phages, leading to a ten-fold reduction in Lactococcus levels among Parkinson’s patients.(7)

This decline in dopamine-producing Lactococcus bacteria could potentially contribute to the neurodegeneration characteristic of Parkinson’s disease. Additionally, reductions in other common gut bacteria, such as Streptococcus spp. and Lactobacillus spp., were also observed in Parkinson’s patients. 

The lead researcher highlighted the association between the depletion of Lactococcus due to the high presence of virulent, lytic phages and the decrease in dopamine levels, as well as the emergence of gastrointestinal symptoms in Parkinson’s patients. 

Specifically, the study identified two groups of lytic phages, c2-like and 936 groups, commonly found in dairy products, responsible for the reduction in Lactococcus. This discovery suggests that there could be potential links between dietary factors, environmental elements, and the development of neurodegenerative conditions. 

While these findings offer promising avenues for further exploration, researchers emphasize that there is still a need for additional comprehensive investigations in order to establish concrete conclusions. 

Other Potential Uses of Bacteriophages

Bacteriophages have shown potential in various areas beyond their role in combating bacterial infections and their role in Parkinson’s. Some of their applications and potential uses include:

  • Alternatives to Antibiotics: Phages can serve as an alternative or adjunct to antibiotics in treating bacterial infections. They can target specific bacterial strains without affecting beneficial bacteria, potentially reducing the development of antibiotic resistance.(8
  • Food Safety: Phages can be used in food processing to control harmful bacteria, enhancing food safety. They are employed in the agricultural sector to prevent bacterial contamination in crops and livestock.(9)
  • Biotechnology and Research: In laboratories, phages are valuable tools in molecular biology and genetics research. They aid in studying bacterial genetics, gene editing, and understanding biological mechanisms.(10)
  • Wastewater Treatment: Phages have applications in wastewater treatment by targeting and controlling harmful bacteria present in sewage, contributing to cleaner water resources.(11)
  • Phage Therapy: This involves using phages as therapeutic agents to target bacterial infections in humans. Research continues on their potential to treat bacterial infections that are resistant to antibiotics.(12)
  • Environmental Protection: Phages can potentially be used to control bacterial pathogens in environmental settings, reducing contamination and the spread of diseases in ecosystems.
  • Bioremediation: In some cases, phages have been explored for their potential to target and degrade specific pollutants or contaminants in the environment.(13)

While the potential of phages is vast and promising, their use in various applications is still being studied and developed. Research continues to explore their effectiveness, safety, and practical applications in diverse fields beyond combating bacterial infections. 

Other Tips to Manage Parkinson’s Disease

While we wait for research on bacteriophages to confirm its benefits for Parkinson patients, there are some other tips that can help in managing this condition. It is important to remember that managing Parkinson’s disease involves a multidisciplinary approach tailored to an individual’s specific symptoms and needs. 

  1. Medication Adherence: Follow the prescribed medication regimen strictly. These medications can help control symptoms and improve quality of life.
  2. Regular Exercise: Engage in regular physical activity to maintain flexibility, balance, and mobility. Exercise programs specifically designed for Parkinson’s, such as tai chi, yoga, dancing, or walking, can be beneficial.(14)
  3. Physical and Occupational Therapy: Work with physical and occupational therapists to develop an exercise routine, improve mobility, and learn techniques to manage daily activities more effectively.(15)
  4. Speech Therapy: Speech therapy can help manage speech and swallowing difficulties that may arise due to Parkinson’s.(16)
  5. Balanced Nutrition: Maintain a healthy and balanced diet to support overall health. Consider consulting a nutritionist for dietary recommendations tailored to manage Parkinson’s symptoms.
  6. Adequate Rest: Prioritize good sleep hygiene to ensure proper rest, as sleep disturbances can be common in Parkinson’s.
  7. Stress Management: Practice stress-relief techniques such as mindfulness, meditation, or relaxation exercises to manage stress, which can exacerbate symptoms.
  8. Support Groups: Join support groups or connect with others living with Parkinson’s to share experiences, gain support, and find coping strategies.
  9. Home Modifications: Make necessary modifications in the living environment to enhance safety and ease mobility, such as installing grab bars, ramps, or adaptive equipment.
  10. Regular Medical Follow-ups: Stay in touch with healthcare professionals, including neurologists and other specialists, for regular check-ups and adjustments in treatment plans as needed.

Remember that each person’s experience with Parkinson’s disease is unique and it is essential to work closely with your healthcare providers to create a personalized care plan that addresses your symptoms and challenges.

Conclusion

The emerging research exploring the potential link between bacteriophages and Parkinson’s disease presented an intriguing avenue for understanding the condition’s development. Recent studies suggest that specific phages targeting certain gut bacteria, such as Lactococcus, may be associated with alterations in the gut microbiota observed in Parkinson’s patients. These findings hint at a potential interplay between gut microbiota, bacteriophages, and the neurodegenerative processes involved in Parkinson’s disease. However, further investigations are still needed to find out more about the exact mechanisms and determine whether these phages actually play a causative role or are simply there as a consequence of the disease itself. Understanding this relationship might offer some innovative insights into Parkinson’s pathology and potentially pave the way for novel therapeutic approaches. 

References:

  1. Clokie, M.R. ed., 2009. Bacteriophages (Vol. 501). Leicester, UK:: Humana Press.
  2. Hendrix, R.W., 2002. Bacteriophages: evolution of the majority. Theoretical population biology, 61(4), pp.471-480.
  3. EurekAlert! (n.d.). Bacteriophages: Are they an overlooked driver of Parkinson’s disease? [online] Available at: https://www.eurekalert.org/news-releases/470468 [Accessed 14 Dec. 2023].
  4. ASM.org. (n.d.). ASM Microbe | Overview. [online] Available at: https://asm.org/Events/ASM-Microbe/Home.
  5. Poirier, A.A., Aubé, B., Côté, M., Morin, N., Di Paolo, T. and Soulet, D., 2016. Gastrointestinal dysfunctions in Parkinson’s disease: symptoms and treatments. Parkinson’s Disease, 2016.
  6. Djordjevic, G.M. and Klaenhammer, T.R., 1997. Genes and gene expression in Lactococcus bacteriophages. International dairy journal, 7(8-9), pp.489-508.
  7. Pietrucci, D., Cerroni, R., Unida, V., Farcomeni, A., Pierantozzi, M., Mercuri, N.B., Biocca, S., Stefani, A. and Desideri, A., 2019. Dysbiosis of gut microbiota in a selected population of Parkinson’s patients. Parkinsonism & Related Disorders, 65, pp.124-130.
  8. Burrowes, B., Harper, D.R., Anderson, J., McConville, M. and Enright, M.C., 2011. Bacteriophage therapy: potential uses in the control of antibiotic-resistant pathogens. Expert review of anti-infective therapy, 9(9), pp.775-785.
  9. Garcia, P., Martinez, B., Obeso, J.M. and Rodriguez, A., 2008. Bacteriophages and their application in food safety. Letters in applied microbiology, 47(6), pp.479-485.
  10. Haq, I.U., Chaudhry, W.N., Akhtar, M.N., Andleeb, S. and Qadri, I., 2012. Bacteriophages and their implications on future biotechnology: a review. Virology journal, 9(1), pp.1-8.
  11. Withey, S., Cartmell, E., Avery, L.M. and Stephenson, T., 2005. Bacteriophages—potential for application in wastewater treatment processes. Science of the total environment, 339(1-3), pp.1-18.
  12. Malik, D.J., Sokolov, I.J., Vinner, G.K., Mancuso, F., Cinquerrui, S., Vladisavljevic, G.T., Clokie, M.R., Garton, N.J., Stapley, A.G. and Kirpichnikova, A., 2017. Formulation, stabilisation and encapsulation of bacteriophage for phage therapy. Advances in colloid and interface science, 249, pp.100-133.
  13. Cristobal-Cueto, P., García-Quintanilla, A., Esteban, J. and García-Quintanilla, M., 2021. Phages in food industry biocontrol and bioremediation. Antibiotics, 10(7), p.786.
  14. Oguh, O., Eisenstein, A., Kwasny, M. and Simuni, T., 2014. Back to the basics: regular exercise matters in Parkinson’s disease: results from the National Parkinson Foundation QII registry study. Parkinsonism & related disorders, 20(11), pp.1221-1225.
  15. Jansa, J. and Aragon, A., 2015. Living with Parkinson’s and the emerging role of occupational therapy. Parkinson’s Disease, 2015.
  16. Robertson, S.J. and Thomson, F., 1984. Speech therapy in Parkinson’s disease: a study of the efficacy and long term effects of intensive treatment. British Journal of Disorders of Communication, 19(3), pp.213-224.

Also Read:

Team PainAssist
Team PainAssist
Written, Edited or Reviewed By: Team PainAssist, Pain Assist Inc. This article does not provide medical advice. See disclaimer
Last Modified On:January 8, 2024

Recent Posts

Related Posts